Antiphospholipid Syndrome (APS) research hub
3 indexed studies · 3 currently recruiting
- enrolling by invitationPHASE1
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
This study is looking at a new treatment called RAY121 for people with certain immune conditions like lupus-like disorders, skin blistering, or blood problems. It's a long-term follow-up for people who did well in an earlier study, to see how RAY121 works over time and if it continues to help.
Australia · Austria · Bulgaria - recruiting
Follow-up Cohort of Patients With Antiphospholipid Syndrome
This study looks at people with Antiphospholipid Syndrome (APS) to understand how many experience new blood clots. Researchers want to update older information and see if newer medicines are making a difference, helping us learn more about this condition.
France - recruitingPHASE1
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
This study is testing a new medicine, RAY121, for several immune system diseases like Antiphospholipid Syndrome and Behçet's Syndrome. Researchers want to see if RAY121 is safe and how it works in the body. It's an early-stage trial.
United States · Australia · Austria